HopeStage
Back to all studies
RecruitingNCT06961968

Iloperidone injection to prevent schizophrenia relapse

About this titleRead the official source — NCT06961968
Medication studyAges 18–65United States
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
Rogers and 21 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 14, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
400
Sponsor
Vanda Pharmaceuticals
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06961968
Official title
Show the full official title

A Multicenter, Double-Blind, Randomized Withdrawal Study in Patients With Schizophrenia Receiving Either Iloperidone Long-Acting Injection (LAI) or Placebo Injection

Recruitment & locations

Currently recruiting

Rogers · Costa Mesa · Lemon Grove

19 more locations
  • Oceanside
  • Pico Rivera
  • San Diego
  • Walnut Creek
  • North Miami
  • Atlanta
  • Peachtree Corners
  • Chicago
  • Flowood
  • Saint Charles
  • St Louis
  • Las Vegas
  • Marlton
  • Staten Island
  • Austin
  • Houston
  • Irving
  • Richardson
  • Bellevue

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Vanda Pharmaceuticals.

Does this study involve medication?

Yes. The study involves medication, including iloperidone and placebo.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies